Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Saizen for idiopathic short stature in children
CTR20180800Phase 3Completed
- Sponsor
- Changchun GeneScience Pharmaceutical Co., Ltd.
- Start
- Jul 2018
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of somatropin in Idiopathic Short Stature (ISS), sponsored by Changchun GeneScience Pharmaceutical Co., Ltd.. Started Jul 2018; status: completed.
02
Drugs
somatropin
03
Conditions
Idiopathic Short Stature (ISS)
Beyond the preview
Go deeper on CTR20180800.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20180800.